References

Camps T, Amat M, Manteca X. A Review of Medical Conditions and Behavioral Problems in Dogs and Cats. Animals. 2019; 9:(12) https://doi.org/10.3390%2Fani9121133

DePorter T, Horwitz D, Landsberg GM. Tools of the trade: Psychopharmacology and Nutrition. In: Rodan I, Heath S (Eds). : Elsevier Health Sciences; 2016

Mills DS. Perspectives on assessing the emotional behavior of animals with behavior problems. Curr Opin Behav Sci. 2017; 16:66-72 https://doi.org/10.1016/j.cobeha.2017.04.002

Mills DS, Demontigny-Bédard Gruen M Pain and Problem Behavior in Cats and Dogs. Animals (Basel). 2020; 10:(2)

Overall K. Manual of Clinical Behavioural Medicine for Dogs and Cats.: Elsevier, Mosby; 2013

Plumb DC. Plumb's Veterinary Drug Handbook, 9th edn. : Wiley; 2018

Preskorn SH. Prediction of individual response to antidepressants and antipsychotics: an integrated concept. Dialogues Clin Neurosci. 2014; 16:(4)545-554 https://doi.org/10.31887%2FDCNS.2014.16.4%2Fspreskorn

Riemer S, Heritier C, Windschnurer I, Pratsch L, Arhant C, Affenzeller N. A Review on Mitigating Fear and Aggression in Dogs and Cats in a Veterinary Setting. Animals. 2021; 11:(1) https://doi.org/10.3390/ani11010158

Roshier AL, McBride EA. Canine behaviour problems: discussions between veterinarians and dog owners during annual booster consultations. Vet Rec. 2013; 172:(9) https://doi.org/10.1136/vr.101125

Sinn L. Advances in Behavioral Psychopharmacology. Vet Clin North Am Small Anim Pract. 2018; 48:(3)457-471 https://doi.org/10.1016/j.cvsm.2017.12.011

Tondo L, Baldessarini RJ. Discontinuing psychotropic drug treatment. BJPsych Open. 2020; 6:(2) https://doi.org/10.1192/bjo.2020.6

Van Haaften K.A. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. JAVMA. 2017; 251:(10)1175-1181

Veterinary Medicines Directorate. The Cascade: prescribing unauthorised medicines. 2021. https://www.gov.uk/guidance/the-cascade-prescribing-unauthorised-medicines (Accessed 30 September 2021)

Zhou C, Zhong J, Zou B, Fang L, Chen J, Deng X Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS ONE. 2017; 12:(2) https://doi.org/10.1371/journal.pone.0172270

Using psychopharmacology in the treatment of problem behaviours in dogs and cats

02 October 2021
20 mins read
Volume 26 · Issue 9
Figure 1. The Veterinary Medicines Directorate prescribing cascade.
Figure 1. The Veterinary Medicines Directorate prescribing cascade.

Abstract

Behaviourally-active medication can play an important role in improving the welfare of cats and dogs in both the short and longer term. Drugs can be used to reduce fear, anxiety and panic in the short term, such as to help noise-sensitive dogs cope better with events such as firework displays, or to help fearful dogs and cats cope better with visits to the vets or groomers. Drugs can also play an important role in longer-term reduction of negative emotional states, particularly fear and anxiety, as long as they are used in conjunction with a comprehensive behaviour modification plan. This article outlines some of the behaviourally-active drugs most commonly used to treat dogs and cats in the UK, as well as some of the considerations needed for using medication as part of behaviour modification in cats and dogs.

Behavioural medication is certainly not necessary or appropriate for every animal showing problem behaviour. Some behaviours perceived to be problematic by owners, such as chasing, digging and marking-related behaviours such as cats scratching furniture, can be normal species-specific behaviours associated with a positive emotional response. These behaviours will generally respond well to management and the provision of more appropriate outlets for these behaviours (Overall, 2013). Even where a problem behaviour is associated with distress or a negative emotional response, if the context and triggers are predictable and avoidable an animal may also respond to environmental management and behavioural modification, without medication.

Medication is most likely to be useful in cases where:

Medical problems are a very common cause of behaviour changes in dogs and cats (Camps et al, 2019) and it is important to identify or rule this out as a cause of problem behaviour. For example. pain can cause or exacerbate a wide variety of problem behaviours including aggression, abnormal repetitive behaviours, anxiety and fearfulness (Mills et al, 2020). In many cases, a change in behaviour may be the only obvious sign of an underlying medical problem. It is therefore essential that any animal presenting with a new problem behaviour, or a change in an existing problem behaviour, receives a thorough health check before referral to a behaviourist, and before the use of behavioural medication is considered. This is important primarily to ensure the welfare of the patient, as starting behavioural medication may delay their access to more appropriate treatments such as pain relief. In addition, behavioural therapy is less likely to be effective if an underlying, undiagnosed medical condition is present. It is also important to rule out the presence of medical conditions that might cause particular drugs to be contraindicated, especially before the use of longer-term medication. The presence of a medical condition does not necessarily preclude the use of behaviourally-active medication, but it is important that any medical condition that could be contributing to a problem behaviour is recognised and addressed before treatment with behaviourally-active medication is begun.

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.